October 14, 2020
Bloomberg Law
As the Supreme Court of the United States prepares to take on Arthrex Inc. v. Smith & Nephew Inc. to determine the constitutionality of administrative patent judges, practitioners weigh in on how the decision will impact the hundreds of cases that were previously remanded back to the Patent Trial and Appeal Board (PTAB) by the U.S. Court of Appeals for the Federal Circuit. Bloomberg Law interviewed Finnegan partner and leader of the firm’s appellate section, Mike Jakes, who said that the Supreme Court’s decision to review Arthrex “leaves us in limbo” with the cases that were remanded back to the PTAB.
Read the full article here.
Award/Ranking
Best Lawyers in Germany Recognizes Dr. Dr. Jochen Herr in Recent Rankings
July 16, 2026
Commentary
Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects
June 30, 2026
Award/Ranking
Finnegan’s European Practices and Attorneys Highlighted in 2026 Managing IP Rankings
June 25, 2026
Press Release
BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret
June 23, 2026
Award/Ranking
Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers
June 22, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.